Anupam Rasayan to build Rs. 4,000+ crore integrated life sciences and CDMO platform
Acquired Tanfac Industries, Jayhawk Fine Chemicals and Bliss GVS Pharma in last 4 years
Acquired Tanfac Industries, Jayhawk Fine Chemicals and Bliss GVS Pharma in last 4 years
Steps up deep-tech product push
Under the agreement, SciBrunch will receive $400 million upfront and could collect additional payments tied to development
Export momentum to provide lift; cost pressures to trim margins by 150-200 bps
Singh also highlighted the role of science and technology in tackling emerging healthcare challenges
The system combines a Riva Anchor SI joint fusion implant with the company’s Riva Posterior Pedicle Fixation System
Under the agreement, LIB Therapeutics will receive upfront and milestone payments, plus net sales royalties
The transaction was executed via Dr. Lal PathLabs FZCO
Biocon Malaysia bags UK MHRA nod for new Insulin fill-finish line
Under the terms of the deal, Jagsonpal will pay an upfront initial consideration of Rs. 23.7 crore at closing
Zydus Lifesciences' New Jersey Office clears USFDA inspection with zero observations
The company had earlier intimated that Phase I of the Greenfield facility commenced commercial production with effect from March 11, 2025
IOL Chemicals and Pharmaceuticals obtains EU-REACH registration for Triacetin
New research shows alpha-hydroxybutyrate can identify increased type 2 diabetes risk nearly a decade before diagnosis; DirectSens technology enables routine clinical chemistry testing
The Health & Pharma Business Unit continued to face intense competition and pricing pressure
Targets 10 million more young people by 2030
The new 1.29 lakh sq. ft. facility integrates molding, extrusion, and cleanroom manufacturing, expanding SJML’s precision medical component and diagnostic capabilities
The programme will establish a scalable manufacturing process for CanVirex's lead candidate, expressing IL-12, targeting advanced solid tumours
Subscribe To Our Newsletter & Stay Updated